Nabilone for non-motor symptoms of Parkinson’s disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)

Although open-label observations report a positive effect of cannabinoids on non-motor symptoms (NMS) in Parkinson’s disease (PD) patients, these effects remain to be investigated in a controlled trial for a broader use in NMS in PD patients. Therefore, we decided to design a proof-of-concept study...

Descripción completa

Detalles Bibliográficos
Autores principales: Peball, Marina, Werkmann, Mario, Ellmerer, Philipp, Stolz, Raphaela, Valent, Dora, Knaus, Hans-Günther, Ulmer, Hanno, Djamshidian, Atbin, Poewe, Werner, Seppi, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2019
Materias:
Neurology and Preclinical Neurological Studies - Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647387/
https://www.ncbi.nlm.nih.gov/pubmed/31129719
http://dx.doi.org/10.1007/s00702-019-02021-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647387/
https://www.ncbi.nlm.nih.gov/pubmed/31129719
http://dx.doi.org/10.1007/s00702-019-02021-z

Ejemplares similares